NeuroNOS

NeuroNOS is a biopharmaceutical company dedicated to developing innovative treatments for Autism Spectrum Disorder (ASD) and other neurological conditions. The company focuses on regulating nitric oxide (NO) levels in the brain, aiming to address the biological mechanisms underlying ASD and improve cognitive and behavioral functions.

Domain

neuro-nos.com

Industry

Biopharma

Employees

1-10

Last Funding

$2.0M

Founded

2022

Frequently Asked Questions

What technologies does NeuroNOS use?+

NeuroNOS uses 16 technologies including AOS, core-js, HubSpot.

What industry is NeuroNOS in?+

NeuroNOS operates in the Biopharma industry.

Where is NeuroNOS based?+

NeuroNOS is headquartered in United States.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026